CATX logo

Perspective Therapeutics (CATX) Retained Earnings

Annual Retained Earnings

-$152.44 M
-$46.51 M-43.90%

December 1, 2023


Summary


Performance

CATX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCATXbalance sheetmetrics:

Quarterly Retained Earnings

-$191.55 M
-$15.12 M-8.57%

September 1, 2024


Summary


Performance

CATX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCATXbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

CATX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.9%-49.9%
3 y3 years-66.9%-80.2%
5 y5 years-80.4%-80.2%

CATX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-66.9%at low-101.3%at low
5 y5-year-80.4%at low-122.2%at low
alltimeall time-4389.6%+97.8%-3564.2%at low

Perspective Therapeutics Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$191.55 M(+8.6%)
Jun 2024
-
-$176.43 M(+7.1%)
Mar 2024
-
-$164.72 M(+8.1%)
Dec 2023
-$152.44 M(+43.9%)
-$152.44 M(+19.3%)
Sep 2023
-
-$127.77 M(+8.8%)
Jun 2023
-
-$117.41 M(+10.4%)
Mar 2023
-
-$106.30 M(+3.5%)
Dec 2022
-$105.93 M(+7.4%)
-
Sep 2022
-
-$102.67 M(+4.1%)
Jun 2022
-
-$98.60 M(+2.2%)
Jun 2022
-$98.60 M(+8.0%)
-
Mar 2022
-
-$96.52 M(+1.4%)
Dec 2021
-
-$95.17 M(+1.7%)
Sep 2021
-
-$93.57 M(+2.5%)
Jun 2021
-$91.33 M(+3.9%)
-
Jun 2021
-
-$91.33 M(+1.2%)
Mar 2021
-
-$90.26 M(+0.8%)
Dec 2020
-
-$89.52 M(+1.0%)
Sep 2020
-
-$88.65 M(+0.8%)
Jun 2020
-$87.94 M(+4.1%)
-$87.94 M(+1.4%)
Mar 2020
-
-$86.75 M(+0.6%)
Dec 2019
-
-$86.20 M(+1.1%)
Sep 2019
-
-$85.31 M(+1.0%)
Jun 2019
-$84.49 M(+6.5%)
-$84.49 M(+1.3%)
Mar 2019
-
-$83.40 M(+1.4%)
Dec 2018
-
-$82.27 M(+1.7%)
Sep 2018
-
-$80.86 M(+1.9%)
Jun 2018
-$79.35 M(+9.3%)
-$79.35 M(+3.1%)
Mar 2018
-
-$76.95 M(+1.8%)
Dec 2017
-
-$75.61 M(+2.0%)
Sep 2017
-
-$74.15 M(+2.1%)
Jun 2017
-$72.60 M(+9.3%)
-$72.60 M(+2.6%)
Mar 2017
-
-$70.75 M(+2.0%)
Dec 2016
-
-$69.39 M(+2.1%)
Sep 2016
-
-$67.94 M(+2.3%)
Jun 2016
-$66.44 M(+7.6%)
-$66.44 M(+1.8%)
Mar 2016
-
-$65.26 M(+1.9%)
Dec 2015
-
-$64.06 M(+2.1%)
Sep 2015
-
-$62.75 M(+1.7%)
Jun 2015
-$61.73 M(+6.3%)
-$61.73 M(+1.7%)
Mar 2015
-
-$60.70 M(+1.6%)
Dec 2014
-
-$59.74 M(+1.5%)
Sep 2014
-
-$58.84 M(+1.4%)
Jun 2014
-$58.05 M(+11.4%)
-$58.05 M(+3.0%)
Mar 2014
-
-$56.37 M(+3.8%)
Dec 2013
-
-$54.29 M(+1.7%)
Sep 2013
-
-$53.36 M(+2.4%)
Jun 2013
-$52.09 M(+8.0%)
-$52.09 M(+1.9%)
Mar 2013
-
-$51.10 M(+1.4%)
Dec 2012
-
-$50.38 M(+2.3%)
Sep 2012
-
-$49.23 M(+2.1%)
Jun 2012
-$48.23 M
-$48.23 M(+2.6%)
Mar 2012
-
-$47.03 M(+1.2%)
Dec 2011
-
-$46.48 M(+1.4%)
DateAnnualQuarterly
Sep 2011
-
-$45.85 M(+2.5%)
Jun 2011
-$44.75 M(+6.8%)
-$44.75 M(+1.6%)
Mar 2011
-
-$44.03 M(+2.4%)
Dec 2010
-
-$43.00 M(+0.5%)
Sep 2010
-
-$42.78 M(+2.1%)
Jun 2010
-$41.90 M(+10.7%)
-$41.90 M(+2.7%)
Mar 2010
-
-$40.82 M(+2.8%)
Dec 2009
-
-$39.73 M(+2.4%)
Sep 2009
-
-$38.78 M(+2.4%)
Jun 2009
-$37.87 M(+19.4%)
-$37.87 M(+3.4%)
Mar 2009
-
-$36.62 M(+4.2%)
Dec 2008
-
-$35.14 M(+4.9%)
Sep 2008
-
-$33.50 M(+5.7%)
Jun 2008
-$31.71 M(+37.0%)
-$31.71 M(+4.8%)
Mar 2008
-
-$30.27 M(+7.7%)
Dec 2007
-
-$28.10 M(+11.0%)
Sep 2007
-
-$25.31 M(+9.3%)
Jun 2007
-$23.15 M(+70.9%)
-$23.15 M(+13.4%)
Mar 2007
-
-$20.42 M(+11.0%)
Dec 2006
-
-$18.39 M(+11.6%)
Sep 2006
-
-$16.47 M(+21.6%)
Jun 2006
-$13.55 M(-99.8%)
-$13.55 M(+24.0%)
Mar 2006
-
-$10.93 M(+17.9%)
Dec 2005
-
-$9.27 M(+27.2%)
Sep 2005
-
-$7.29 M(+4.6%)
Jun 2005
-$6.99 B(>+9900.0%)
-
Mar 2005
-
-$6.97 M(-4.2%)
Dec 2004
-
-$7.27 M(+0.0%)
Sep 2004
-$7.27 M(-1.0%)
-$7.27 M(+0.1%)
Jun 2004
-
-$7.26 M(-1.2%)
Mar 2004
-
-$7.36 M(+0.1%)
Dec 2003
-
-$7.35 M(+0.1%)
Sep 2003
-$7.34 M(+0.8%)
-$7.34 M(+0.1%)
Jun 2003
-
-$7.33 M(+0.2%)
Mar 2003
-
-$7.32 M(+0.2%)
Dec 2002
-
-$7.30 M(+0.3%)
Sep 2002
-$7.28 M(+0.8%)
-$7.28 M(+0.2%)
Jun 2002
-
-$7.27 M(+0.2%)
Mar 2002
-
-$7.26 M(+0.2%)
Dec 2001
-
-$7.24 M(+0.2%)
Sep 2001
-$7.23 M(-3.2%)
-$7.23 M(-3.8%)
Jun 2001
-
-$7.51 M(+0.3%)
Mar 2001
-
-$7.49 M(+0.2%)
Dec 2000
-
-$7.48 M(+0.2%)
Sep 2000
-$7.46 M(+42.7%)
-$7.46 M(+0.4%)
Jun 2000
-
-$7.43 M(+0.2%)
Mar 2000
-
-$7.42 M(+41.6%)
Dec 1999
-
-$5.24 M(+0.2%)
Sep 1999
-$5.23 M(-25.9%)
-$5.23 M
Sep 1998
-$7.05 M(+2.0%)
-
Sep 1997
-$6.91 M(+6.6%)
-
Sep 1996
-$6.49 M(+49.6%)
-
Sep 1995
-$4.33 M(+27.7%)
-
Sep 1994
-$3.40 M
-

FAQ

  • What is Perspective Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Perspective Therapeutics?
  • What is Perspective Therapeutics annual retained earnings year-on-year change?
  • What is Perspective Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Perspective Therapeutics?
  • What is Perspective Therapeutics quarterly retained earnings year-on-year change?

What is Perspective Therapeutics annual retained earnings?

The current annual retained earnings of CATX is -$152.44 M

What is the all time high annual retained earnings for Perspective Therapeutics?

Perspective Therapeutics all-time high annual retained earnings is -$3.40 M

What is Perspective Therapeutics annual retained earnings year-on-year change?

Over the past year, CATX annual retained earnings has changed by -$46.51 M (-43.90%)

What is Perspective Therapeutics quarterly retained earnings?

The current quarterly retained earnings of CATX is -$191.55 M

What is the all time high quarterly retained earnings for Perspective Therapeutics?

Perspective Therapeutics all-time high quarterly retained earnings is -$5.23 M

What is Perspective Therapeutics quarterly retained earnings year-on-year change?

Over the past year, CATX quarterly retained earnings has changed by -$63.78 M (-49.92%)